Pure Cycle vs York Water
PCYO and YORW side by side, both in water supply. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PCYO and YORW compare
York Water is the larger company, worth 2.0 times as much as Pure Cycle ($505M against $259M).
On earnings, Pure Cycle is cheaper: it trades at 17.6× trailing earnings, against 19.3× for York Water.
Pure Cycle grew revenue faster over the last twelve months (22.9% versus 9.4% for York Water).
Pure Cycle keeps more of each dollar of sales as profit, with a net margin of 43.7% compared with 28.5% at York Water.
York Water pays a dividend yielding 2.9%; Pure Cycle does not pay one.
Pure Cycle scores higher on the StockData Score (15 against 14 for York Water), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PCYO | YORW |
|---|---|---|
| Size and price | ||
| Market cap | $259M | $505M |
| Share price | $10.73 | $31.13 |
| Change, 1 year | −3.4% | −3.3% |
| Change, 5 years | −28.6% | −33.0% |
| Beta (5Y) | 0.53 | −0.12 |
| Employees | 44 | 129 |
| StockData Score | ||
| Total score | 15 (better) | 14 |
| Valuation score | 5 | 5 |
| Growth score | 2 | 2 |
| Performance score | 3 (better) | 2 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 17.6× (better) | 19.3× |
| P/S | 7.7× | 6.1× (better) |
| P/B | 1.7× (better) | 1.7× |
| EV/EBITDA | 17.5× | 15.4× (better) |
| PEG | 1.67 | – |
| Fair value | $13.28 | $34.39 |
| Margin of safety | 19.2% (better) | 9.5% |
| Growth | ||
| Revenue growth (TTM) | 22.9% (better) | 9.4% |
| Revenue growth, 5Y average | 0.18% | 7.5% (better) |
| Net income growth (TTM) | 8.2% | 20.8% (better) |
| EPS growth (TTM) | 10.9% | 17.5% (better) |
| EPS growth, 5Y average | 14.0% (better) | 1.8% |
| Profitability | ||
| Gross margin | 62.0% | – |
| Operating margin | 37.7% (better) | 36.6% |
| Net margin | 43.7% (better) | 28.5% |
| Return on equity | 10.2% (better) | 9.0% |
| Return on invested capital | 6.7% (better) | 6.5% |
| Financial health | ||
| Debt / equity | 0.09 (better) | 0.64 |
| Net debt / EBITDA | 0.38 (better) | 4.21 |
| Interest coverage | 25.4× (better) | 3.0× |
| Current ratio | 1.53 (better) | 1.05 |
| Altman Z-score | 6.63 (better) | 1.21 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.9% |
| Payout ratio | – | 54.2% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 4.0% |
| Buyback yield | – | −9.7% |
| Shareholder yield | 0.00% (better) | −6.8% |
| Ownership | ||
| Held by institutions | 54.3% | 64.4% |
| Held by insiders | 29.7% | 1.1% |
| Insider net buying, 12 months | $0 (better) | −$122K |
| Short interest, % of float | 2.4% | 3.2% |
Go deeper
- PCYO stock overview
- PCYO income statement
- PCYO valuation and score
- YORW stock overview
- YORW income statement
- YORW valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.